In neurons, activity-dependent association of dendritically transported mRNA transcripts with the transacting factor CBF-A is mediated by A2RE/RTS elements 
INTRODUCTION
Transport and localization of mRNA transcripts to subcellular compartments occurs in many cell types and provides temporal and spatial control of gene expression. These mechanisms are dependent on the interplay between cis-acting elements located in the 3′ or 5′ untranslated regions (UTRs) of the transported mRNAs with a set of transacting factors (Rodrigues et al., 2008; Martin and Ephrussi, 2009; Percipalle et al., 2009) . In fibroblasts and neurons, transport of the β-actin mRNA to leading edge and synapses is mediated by the cis-acting element zipcode, which is recognized by ZBP1 (Eom et al., 2003; Tiruchinapalli et al., 2003; Condeelis and Singer, 2005; Huttelmayer et al., 2005) . In oligodendrocytes, the myelin basic protein (MBP) mRNA is transported to the myelin compartment (Carson et al., 2001; Carson and Barbarese, 2005; Percipalle et al., 2009) . In its 3′ UTR, the MBP mRNA has a specific cis-acting element termed A2RE (hnRNP A2 response element) or more generally RTS (RNA trafficking sequence). This sequence is specifically recognized by fibers of dendrites as revealed by costaining with the dendrite marker MAP2 ( Figure 1D ). Furthermore, coimmunostaining with the anti-CBF-A antibody ICCI and a mouse monoclonal antibody (mAb) against the presynaptic marker synapsin 1 revealed that CBF-A is located close to synapses (Figure 1, E and F) . Distinctive nuclear staining as well as CBF-A-positive granules along dendrites were also revealed by double immunofluorescence staining performed on rat hippocampal neurons using ICCI and the MAP2 antibody (Figure 2A ), as well as antibodies to synapsin 1 and postsynaptic density 95 (PSD95) (Supplemental Figure 1) . These experiments were further validated with the anti-CBF-A antibody SAK22 raised against the CBF-A N terminus (Dean et al., 2002) and known to react with both p37 and p42 splice variants (Supplemental Figure 2) . Interestingly, in double immunostainings of hippocampal neurons the signals obtained from ICCI and SAK22 displayed a linear correlation, and more than 80% overlap (Figure 2 , B and C), supporting their specificity.
To further characterize the in vivo localization of CBF-A, we next carried out immuno-electron microcopy (IEM) experiments on thin sections of adult mouse brain. Sections of hippocampus the heterogeneous nuclear ribonucleoproteins (hnRNP) A2 and CArG Box binding Factor A (CBF-A) (Ainger et al., 1993; Hoek et al., 1998; Raju et al., 2008) . In mammals, CBF-A is also known as hnRNP A/B. Similarly to hnRNP A2, CBF-A belongs to the A/B-type hnRNP subfamily and it is closely related to hnRNP A1 and hnRNP D, being characterized by two conserved RNA binding motifs and a C-terminal auxiliary domain involved in protein-protein interactions (Dreyfuss et al., 2002) . Sequence analysis shows that CBF-A and hnRNP A2 exhibit 40% sequence identity. Consistent with a role as transacting factor, we discovered that CBF-A is part of the same RNP complex as hnRNP A2, and, in mouse oligodendrocytes, CBF-A gene silencing led to impairment of MBP mRNA trafficking. On the basis of these findings we proposed that A2RE/RTS recognition by CBF-A is important to sort transport-competent MBP mRNA to the final cytoplasmic destination (Percipalle et al., 2002 (Percipalle et al., , 2009 Raju et al., 2008) .
In neurons, certain mRNA transcripts are transported to dendrites for localized translation (Bramham and Wells, 2007) . In many cases, dendritic localization is dependent on the UTRs (Lisman et al., 2002; Bramham and Wells, 2007; Jambhekar and DeRisi, 2007; Andreassi and Riccio, 2009; Martin and Ephrussi, 2009) . Even though these mechanisms are compatible with the establishment of excitatory synapses, it remains largely unclear how specific mRNAs are transported and localized to dendrites. RTS and RTS-like sequences were identified in a number of neuronal transcripts (Ainger et al., 1997) , including Arc (activity-regulated cytoskeleton-associated protein) and CaMKIIα (calmodulin-dependent protein kinase II) mRNAs, which are believed to be dendritically transported via the A2RE/RTS pathway Gao et al., 2008) . CBF-A (or hnRNP A/B) is among the hnRNPs that are found in the RNA granules isolated from developing and adult mouse brains (Kanai et al., 2004; Elvira et al., 2006) . Furthermore, CBF-A is a shuttling hnRNP component of premRNP/mRNP particles and in neuron lineages we discovered that CBF-A-positive granules decorate dendrites (Percipalle et al., 2002; Raju et al., 2008) . At this stage, however, it is not known whether CBF-A associates with the putative RTS-like sequences in the UTRs of dendritically transported transcripts and whether CBF-A has a role in trafficking of neuronal mRNAs (Bramham and Wells, 2007; Chua et al., 2010) .
Here we report that CBF-A directly binds the RTSs found in Arc, CaMKIIα, and BDNF (brain-derived neurotrophic factor) mRNAs and accompanies the transcripts from gene to dendrites. Because in hippocampal neurons association is sensitive to postsynaptic receptor activation, we propose that CBF-A has an important role in the trafficking of RTS-containing neuronal mRNAs.
RESULTS

In vivo localization of CBF-A in the adult forebrain
CBF-A is known to be present in two different splice variants termed p37 and p42 (Dean et al., 2002) . Using the polyclonal anti-CBF-A antibody ICCI directed against the unique C-terminal epitope within the p42 variant we performed immunofluorescence staining of sections of adult mouse forebrain. Confocal microscopy confirmed that CBF-A is abundantly expressed in the mouse brain (Raju et al., 2008) and in neurons (Figure 1 ). In double immune labeling experiments we discovered that CBF-A has distinctive nuclear localization and that its distribution correlates with the neuronal nuclear marker NeuN ( Figure 1B) . A fraction of CBF-A was also found outside the cell nucleus in small clusters or discrete particles, reminiscent of dendritically transported mRNA granules, with different sizes and signal intensities depending on the brain regions analyzed (Figure 1 ). These clusters seem to be associated with microtubulin incubated with the anti-CBF-A antibody SAK22 revealed that CBF-A has a widespread distribution, in agreement with the light microscopy results reported earlier in the text (Figure 1 ). Consistent with previous data on the subcellular distribution of CBF-A in oligodendrocytes (Raju et al., 2008) , the anti-CBF-A antibodies revealed a high density of labeling in the nucleus of different types of brain cells, including neurons (see also Figures 1 and 2 as well as Supplemental Figures 1 and 2) . The CBF-A antibodies decorated electrodense structures located in the interchromosomal space (ICS in Figure 3 ) and in the perichromatin area (arrowheads in Figure 2 , C and D), where active transcription takes place (Fakan and Puvion, 1980) . CBF-A was instead excluded from the patches of dense chromatin (DC in Figure 3) . The location and morphology of the CBF-A-positive structures suggests that CBF-A is associated with (pre)-mRNP complexes at the sites of transcription and in the interchromosomal space. CBF-A was also found to be associated with electrodense structures, presumably mRNPs, at the nuclear pores and in transit to the cytoplasm (arrows in Figure 3 , B and D).
In the cytoplasm, significant immunolabeling was observed in myelinized axons ( Figure 4, A and B) . The SAK22 antibody also stained synapses, where immunogold markers were found on both presynaptic and postsynaptic compartments (Figure 4 , E and H). The labeling density in synapses was relatively low compared to that observed in axons but was highly significant as judged by the absence of immunogold in sections processed in parallel with only secondary antibody ( Figure 4D ). We could also detect CBF-A in neuronal cytosol and over nonmyelinized processes. The labeling in axons and synapses was confirmed using the rabbit polyclonal anti-CBF-A antibody ICCI (Supplemental Figure 3) .
In synaptosomal fractions CBF-A associates with RTS-containing mRNA transcripts
To confirm the subcellular localization of CBF-A in neurons, we fractionated brain lysates by ultracentrifugation on sucrose cushions ( Figure 5A ). The fractionated material was analyzed on immunoblots with antibodies against CBF-A as well as antibodies against the postsynaptic marker PSD95 and the nuclear marker histone H3. Consistent with the histological data and previous observations (Raju et al., 2008) , CBF-A was found in nucleus and cytosol as well as in synaptosome-enriched fractions ( Figure 5B ). scrambled version (scrRTS) with identical nucleotide composition as the MBP mRNA RTS but different primary sequence (see Raju et al., 2008) . These RNA oligonucleotides were coupled to streptavidin-coated Sepharose beads, and the beads were incubated with total mouse brain lysates. The blots in Figure 6B show that wtRTS sequences precipitated endogenous CBF-A ( Figure 6B, lanes 4-7) . Control scrRTS or mock beads that were not conjugated with any RNA oligonucleotides did not precipitate CBF-A ( Figure 6B, lanes 2 and 3) . As expected, similar results were obtained with endogenous hnRNP A2. On the contrary, hnRNP U, which is also found in RNA granules isolated from developing and adult mouse brains and the mitochondrial protein Tom20, were not coprecipitated with any of the beads used in the RNA affinity chromatography assays ( Figure 6B ), altogether supporting the specificity of the assay.
We next applied electrophoretic mobility shift assays (EMSAs) to determine whether CBF-A directly binds the RTS motifs. We incubated purified recombinantly expressed glutathione S-transferase-tagged CBF-A (p37 isoform) where the affinity tag had been proteolytically removed with [ 33 P]-labeled RNA oligonucleotides encompassing Arc, CaMKIIα, and BDNF wtRTSs. In parallel, CBF-A was also incubated with control RNA oligonucleotides encompassing scrambled versions of the wtRTS sequences. Figure 6 shows that incubation with CBF-A retarded more efficiently the electrophoretic mobility of wtRTS-containing oligonucleotides in comparison to the scrambled sequences ( Figure 6 , C-E). In addition, gel retardation of wtRTS-containing RNA oligonucleotides incubated with CBF-A was competed in the presence of corresponding unlabeled wtRTS oligonucleotides but not in the presence of unlabeled scrRTS-containing RNA oligonucleotides when added in large amounts to the reaction mixture ( Figure 6 , C-E). Finally, incubation of CBF-A with labeled scrRTS oligonucleotides was sensitive to competition with unlabeled wtRTS oligonucleotides but was not sensitive to competition with unlabeled scrRTS oligonucleotides ( Figure 6 , C-E).
Altogether these results indicate that CBF-A specifically associates with Arc, BDNF, and CaMKIIα mRNAs through direct interactions with their RTS sequences.
In dendrites CBF-A localizes to dynamic mRNA granules
Immunofluorescence staining performed on hippocampal neurons demonstrated that CBF-A is present in dendrites ( Figure 2A ). If CBF-A associates with dendritic mRNAs via their RTS elements, it is likely that CBF-A is found in transported granules. To evaluate the possibility, hippocampal neurons were analyzed by immunofluorescence in situ hybridization (immuno-FISH) with the anti-CBF-A antibody ICCI and specific digoxigenin-labeled RNA probes hybridizing with endogenous Arc, BDNF, and CaMKIIα mRNAs. Confocal microscopy revealed that CBF-A-positive granules distributed along We next applied RNA immunoprecipitation assays to examine whether in synaptosome-enriched P2 fractions CBF-A associates with synaptic mRNAs. Synaptosomal preparations were incubated with the CBF-A antibody ICCI. Total RNA was isolated from immunoprecipitated samples of mouse brain P2 fraction (see Figure 5C ) using the TRI reagent and reverse-transcribed with oligo(dT) primers. The resulting cDNA was analyzed by semiquantitative RT-PCR using specific primers amplifying BDNF, CaMKIIα, and Arc mRNAs. As can be seen, we revealed a specific enrichment in the levels of Arc, BDNF, and CaMKIIα mRNAs coprecipitated with CBF-A ( Figure 5D ). Densitometric quantification revealed a considerable 3-to 10-fold increase in the levels of BDNF, CaMKIIα, and Arc mRNA coprecipitated with CBF-A in comparison to α-tubulin mRNA and control immunoprecipitations carried out with nonspecific immunoglobulin (Ig) Gs (Figure 5, D and E) . We conclude that, in synaptosomal preparations, CBF-A associates with Arc, BDNF, and CaMKIIα mRNAs.
The 3′ UTRs of CaMKIIα and Arc mRNAs contain RTS-like sequences that are closely related to the MBP mRNA RTS (Gao et al., 2008) , and we identified a similar RTS-like sequence in the 3′ UTR of BDNF mRNA ( Figure 6A ). To evaluate whether CBF-A bound any of these sequences, we synthesized biotinylated RNA oligonucleotides encompassing the wild-type (wt)RTS-like sequences present in Arc, BDNF, and CaMKIIα mRNAs and in the MBP mRNA RTS. As control, we used an RNA oligonucleotide encompassing a dendrites and their distributions correlated with the granular structures identified by the FISH signals using antisense probes specific for Arc, BDNF, and CaMKIIα mRNA (Figure 7) . Notably, no FISH signal was detected with sense RNA probes against the corresponding transcripts just mentioned, supporting the specificity of the assay (Supplemental Figure  4) . To evaluate colocalizations of endogenous CBF-A with Arc, BDNF, and CaMKIIα mRNAs, we performed unbiased statistical analysis on the fluorescence intensity levels from individual granules derived from the corresponding confocal images, as previously described (Ma et al., 2002; Raju et al., 2008) . In all cases the results revealed linear correlations between the signals from CBF-A and the RNA transcripts analyzed (Figure 7, D-L) . Quantification of the number of colocalization events occurring in individual particles showed that 60% to 70% of the granules simultaneously contain CBF-A and the RTS-containing Arc, BDNF, and CaMKIIα mRNA. These observations suggest that CBF-A is likely to be incorporated in endogenous mRNA granules containing Arc, BDNF, and CaMKIIα transcripts.
To evaluate whether in dendrites CBF-A-positive granules are dynamically transported, we transiently expressed full-length CBF-A (p37 isoform) tagged with enhanced green fluorescent protein (EGFP) in rat hippocampal neurons. Confocal microscopy showed that the EGFP/CBF-A construct displayed both nuclear distribution and granular clusters in dendrites, overall matching the distribution observed in the case of the endogenous protein ( Figure 8A ). We next performed time-lapse live cell microscopy on hippocampal neurons transiently expressing EGFP/ CBF-A. As can be seen in Figure 8B , we found that a major fraction of EGFP/CBF-A-positive granules were immobile or stationary. A fraction of EGFP/CBF-A-containing granules exhibited an oscillatory movement. Finally, a subset of EGFP/CBF-A-positive granules displayed a single direction motion, anterograde or retrograde, with a calculated speed of 0.028-0.13 μm/s (Figure 8 , B-D), similar to that measured for Staufen 1-, DDX3-, and CaMKIIα mRNA-containing granules (Kohrmann et al. 1999; Rook et al., 2000; Elvira et al., 2006) . Interestingly, we found that in dendrites of hippocampal neurons EGFP/CBF-A-positive granules correlated with the FISH signal from digoxigenin-labeled RNA probes hybridizing with CaMKIIα mRNAs ( Figure 8E ) as well as Arc and BDNF mRNAs (unpublished data). Taken altogether, these observations suggest that in hippocampal neurons a fraction of CBF-A is incorporated in dynamically transported granules which are likely to contain dendritic mRNAs. treated with antagonists or agonists, and in all cases we measured CBF-A signal intensities. We discovered that NMDA and AMPA induced an approximately twofold increase in the levels of CBF-A in dendrites in comparison to untreated cells (Figure 9 , B and C). Only marginal effects were detected upon treatment with the respective agonists ( Figure 9 , B and C). We conclude that, in dendrites, trafficking and localization of endogenous CBF-A is sensitive to postsynaptic receptor stimulation.
Association of CBF-A with dendritic mRNA transcripts is activity-dependent During mRNA biogenesis, hnRNP proteins such as CBF-A are cotranscriptionally associated with nascent transcripts, facilitate RNP assembly, and in many cases accompany the mRNA from gene to polysomes (Visa et al., 1996; Daneholt, 2001; Dreyfuss et al., 2002; Percipalle et al., 2002) .
CBF-A is an abundant nuclear protein that localizes to dendrites, and its distribution is activity dependent. Because the distribution of Arc, BDNF, and CaMKIIα mRNAs is sensitive to NMDA and AMPA treatment (Steward et al., 1998; Bramham and Wells, 2007) , we reasoned that CBF-A association with transported mRNAs may be intrinsically sensitive to synaptic stimulation. To start proving this hypothesis, we stimulated rat hippocampal neurons with NMDA. Next total RNA was extracted and reverse-transcribed with oligo(dT) primers. The resulting cDNA was analyzed by quantitative realtime PCR (qRT-PCR) with primers amplifying Arc, BDNF, and CaMKIIα mRNAs. In at least three independent experiments, we found a 10-20% significant increase in the steady-state levels of Arc, BDNF, and CaMKIIα mRNAs, in all cases normalized against the levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA (Figure 9D) . None of the transcripts were affected upon treatment with the antagonist APV ( Figure 9D ), altogether supporting the view that synaptic stimulation induces increased transcriptional rates of dendritically localized mRNAs (Bramham and Wells, 2007) . We next tested whether NMDA stimulation correlates with increased binding of CBF-A to Arc, BDNF, and CaMKIIα mRNAs. For this purpose, total lysates from NMDA-or APV-treated rat hippocampal neurons were subjected to immunoprecipitations with anti-CBF-A antibodies. Total RNA was extracted and the cDNA analyzed by qRT-PCR. We found that the amounts of Arc, BDNF, and CaMKIIα mRNAs coprecipitated with CBF-A were significantly increased in comparison to APV-treated cells ( Figure 9E ) or untreated cells (unpublished data). As expected, nonspecific IgGs did not pull down any of the transcripts analyzed (unpublished data). Altogether these findings indicate that the specific binding of CBF-A to Arc, BDNF, and CaMKIIα mRNAs correlates with postsynaptic receptor stimulation and supports the view that CBF-A accompanies the transcripts from gene to dendrites.
To test for an involvement of CBF-A in transport of dendritic transcripts, we next silenced the CBF-A gene by RNA interference
Postsynaptic receptor activation leads to increased levels of CBF-A in dendrites
Treatment of hippocampal neurons with the selective agonists NMDA (N-methyl-d-aspartate) and AMPA (α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate) mimics the effects of the neurotransmitter glutamate, leads to synaptic activation, and upregulates dendritic mRNA transcripts, eventually leading to synaptic consolidation (Bramham and Wells, 2007; Tian et al., 2007) . CBF-A is present in postsynaptic densities (Figure 4) . Therefore, because CBF-A binds to Arc, BDNF, and CaMKIIα mRNAs, upon NMDA and AMPA treatment we expect to find increased CBF-A protein levels in dendrites. To test this possibility, we treated hippocampal neurons with the agonists NMDA or AMPA and the corresponding antagonists APV ((2R)-amino-5-phosphonovaleric acid)) and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) as negative controls. After a 4-h treatment, we monitored the distributions of CBF-A and dendrite marker MAP2 by immunofluorescence and confocal microscopy. We found that both NMDA ( Figure 9A ) and AMPA (unpublished data) induced increased levels of CBF-A along dendrites ( Figure 8A ). On the contrary, APV treatment ( Figure 9A ) or treatment with CNQX (unpublished data) did not induce any changes in the CBF-A distribution. To quantify the effects, we randomly selected multiple dendritic regions from 10 independent hippocampal neurons untreated or (RNAi). Hippocampal neurons were transfected with RNA duplexes against target sequences on the CBF-A gene. Steady-state expression of endogenous CBF-A was monitored by immunofluorescence on hippocampal neurons anti-CBF-A antibodies and an anti-MAP2 antibody ( Figure 10A ), whereas the CBF-A mRNA levels were monitored by qRT-PCR ( Figure 10B) . A specific shutdown of the expression resulting in a drop in endogenous CBF-A steady-state level was observed approximately 3 d after transfection (Figure 10, A and B) . To test the effect of CBF-A silencing on the distribution of dendritic mRNA, we performed immuno-FISH on CBF-A-silenced hippocampal neurons and monitored the distribution of CaMKIIα mRNA. We found that CBF-A gene silencing led to a drop in the levels of CaMKIIα mRNA in dendrites (Figure 10 , C and D), whereas in control cells transfected with unrelated RNAi oligonucleotides, dendritic localization of CaMKIIα mRNA granules was not affected (Figure 10, C and D) . For quantification, we randomly selected dendritic regions from nontransfected as well as control and CBF-A silenced hippocampal neurons and in all cases we measured CBF-A and FISH average signals intensities. Concomitantly, with an average 50% specific reduction in the steady-state expression of CBF-A, we observed a twofold drop in the levels of CaMKIIα mRNA in dendrites in comparison to controls ( Figure 10D ). Similar results were obtained for Arc and BDNF mRNA dendritic localization upon CBF-A gene silencing (unpublished data). We conclude that in neurons CBF-A gene knockdown specifically affects mRNA expression levels of transported mRNAs.
DISCUSSION
In the present study we found that the transacting factor CBF-A is abundantly expressed in neurons. In the cytosol, CBF-A is present in dendrites and synapses with a characteristic granular distribution. In synaptosomal preparations from total mouse brain lysates, CBF-A specifically associates with Arc, BDNF, and CaMKIIα mRNAs. A close look at the 3′ UTRs of the transcripts just mentioned shows the presence of RTS elements that are related to the MBP mRNA RTS. Consistent with previous work (Raju et al., 2008) , these RTS elements are specifically and directly recognized by CBF-A. These observations and in situ evidence that in dendrites a fraction of CBF-A colocalizes with all three transcripts suggest that CBF-A is genuinely present in dendritic mRNA granules, presumably with hnRNP A2 (see also Raju et al., 2008) , FIGURE 6: CBF-A directly binds to Arc, BDNF, and CaMKIIα mRNA RTSs. (A) Sequence analysis of 3′ UTRs shows considerable homologies between MBP mRNA RTS and RTS-like sequences in BDNF, CaMKIIα, and ARC mRNAs. (B) CBF-A binds the RTS sequences found in BDNF, CaMKIIα, and ARC mRNAs. Biotinylated wtRTSs from BDNF, CaMKIIα, and MBP mRNA as well as a MBP scrRTS were conjugated to streptavidin Sepharose. Beads were incubated with mouse brain lysates. Bound proteins were resolved by SDS-PAGE and analyzed on immunoblots with antibodies to CBF-A (SAK22) and hnRNP A2B1 and with antibodies against hnRNP U, and the mitochondrial protein Tom20 was used as negative control. (C-E) RTSbinding EMSAs using 33 P-labeled Arc wtRTS and scrRTS (C), BDNF wtRTS and scrRTS (D), and CaMKIIα wtRTS and scrRTS probes (E). To perform EMSAs, wtRTS or scrRTS probes were incubated with purified recombinant CBF-A without affinity tag. Incubations were also performed in the presence or absence of a 50-fold excess of unlabeled competitor RNA oligonucleotides as indicated.
intact but lacks the 3′ UTR the mRNA is restricted to the soma. These animals show reduction of CaMKIIα transcripts in postsynaptic densities, a reduction in late-phase long-term potentiation, and impairments in spatial memory (Miller et al., 2002) . For BDNF, the brain produces two different transcripts, with either short or long 3′ UTRs.
where CBF-A binds Arc, BDNF, and CaMKIIα mRNA through their RTS elements.
The RTS-containing 3′ UTRs of BNDF and CaMKIIα mRNAs play an essential role for localized translation. There is evidence that in mutated mice in which the protein-coding region of CaMKIIα is In mutated mice with truncated long 3′ UTR, dendritic targeting of BDNF mRNAs is impaired, and these animals display selective impairment in long-term potentiation in dendrites of hippocampal neurons . Here we report that CBF-Apositive mRNA granules are dynamic in nature and that their localization in dendrites is activity-dependent. Similarly to Arc, BDNF, and CaMKIIα mRNAs, treatment of hippocampal neurons with NMDA and AMPA, which mimic the effect of the neurotransmitter glutamate, resulted in CBF-A accumulation in dendrites. CBF-A is also present in the characteristic postsynaptic densities where translation of Arc, BDNF, and CaMKIIα mRNAs is believed to take place (Bramham and Wells, 2007) . Therefore it is conceivable that failure in correct localization and targeting of BDNF and CaMKIIα mRNAs upon truncation of their 3′ UTRs in mutated mice partly results from deletion of their RTS elements. Similarly to BDNF and CaMKIIα mRNAs, we predict that Arc mRNA lacking the RTS would not be transported to dendrites. On the basis of these considerations we propose that the RTS sequences in the 3′ UTRs of Arc, BDNF, and CaMKIIα mRNAs are bona fide cis-acting elements required for dendritic trafficking. Given that, in dendrites of CBF-A-silenced hippocampal neurons, we found a twofold drop in the levels of CaMKIIα mRNA, we suggest that CBF-A recognizes RTS elements and functions as transacting factor to facilitate mRNA transport and localization in dendrites. Because association of CBF-A with the RTS-containing mRNAs is sensitive to NMDA treatment, it is likely that the interplay between CBF-A and RTS elements correlates with the function of excitatory synapses.
IEM experiments demonstrated that in the cell nucleus CBF-A localizes in the perichromatin region where active transcription is believed to take place (Rouquette et al., 2010) , presumably coupled to nascent premRNPs as well as mature mRNPs in interchromatin space and passages through the nuclear pore complex. Because CBF-A is a shuttling hnRNP and core component of pre-mRNP/mRNPs (Percipalle et al., 2002) , these observations suggest that CBF-A is ing of CBF-A to RTS elements provides de facto a way to sort transported Arc, BDNF, and CaMKIIα mRNPs at an early stage during RNP biogenesis.
At later stages, when granules have reached their final destinations, there is evidence that hnRNP A2 phosphorylation by Fyn kinase leads to unwinding of the MBP mRNA granule for localized translation (White et al., 2008) , which indicates a structural role for hnRNP A2 in the maintenance of the RNP granule. Similar mechanisms may be envisaged in neurons for dendritic RTS-mediated assembled into mRNP complexes in the nucleus and exported from the nucleus to the cytoplasm as part of mature mRNPs. CBF-A is known to bind the MBP mRNA RTS already in the cell nucleus (Raju et al., 2008) . Therefore, in view of the present findings, it is likely that RTS recognition by CBF-A is important during pre-mRNP assembly. We propose that CBF-A recognizes the RTS elements present in Arc, BDNF, and CaMKIIα mRNAs to facilitate cotranscriptional premRNP assembly, a mechanism that promotes the establishment of transport-competent RNPs. We suggest that cotranscriptional bind- con (now Millipore; Billerica, MA), Cell Signaling Technology (Danvers, MA), and Abcam (Cambridge, UK). The rabbit polyclonal anti-CBF-A antibody ICCI was raised against the peptide YQQGYGPGYGGYDY located in the C terminus of the p42 CBF-A splice variant as described by Raju et al. (2008) . The guinea pig anti-CBF-A antibody SAK22 was designed against the peptide EEQPMETTGATEN located in the N terminus of both p37 and p42 CBF-A isoforms as previously described (Dean et al., 2002) and was purchased from Peptide Specialty Laboratories (Heidelberg, Germany). The mAbs against histone H3, hnRNP U (3G6), and hnRNP A2 were obtained from Abcam, whereas the antiTom20 was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Nonspecific mouse IgGs were obtained from Dako mRNA targeting. In any case, we propose that in the cell nucleus RTS recognition by CBF-A mediates RNP packaging of Arc, BDNF, and CaMKIIα mRNAs through a mechanism that probably leads to nuclear remodeling of their 3′ UTRs. This in turn contributes to keep dendritic mRNAs in a state which is transport-competent and presumably translationally dormant. We speculate that these mechanisms are required for establishment of excitatory synapses and may have a long-term effect on the plasticity of neuronal contacts.
MATERIALS AND METHODS Antibodies
The mouse mAbs against Map2, NeuN, synapsin I, and PSD95 were, respectively, obtained from Sigma (St. Louis, MO), Chemi- Transfection and live cell microscopy on cultured hippocampal neurons Rat hippocampal neurons were grown on poly-d-lysine-coated glass coverslips in 60-mm dishes (Corning, Corning, NY) and transfected at DIV 9-10 with an EGFP/CBF-A expression plasmid (gift from Tomas Leanderson, Lund University, Sweden) using Lipofectamine 2000 as described in the manufacturer's handbook (Invitrogen). The following day, EGFP/CBFA-expressing neurons were imaged with a 40× objective using a Zeiss (Thornwood, NY) LSM510 META laser scanning confocal microscope equipped with heated chamber and humidity control unit at 37°C and 5% CO 2 . Images were acquired every 40 s, and the data were analyzed using ImageJ and the Volocity image analysis software.
IEM on sections of adult mouse brain
Adult mouse brains were fixed following Godsave et al. (2008) with 2% paraformaldehyde (PFA) and 0.2% glutaraldehyde in 0.1 M PHEM buffer (25 mM HEPES, 10 mM EGTA, 60 mM PIPES, 2 mM MgCl 2 , pH 7.2) for 20 h after intracardiac perfusion. Small brain pieces were postfixed for 7 d in 1% PFA and stored in 0.5% PFA in the same buffer, washed with 50 mM glycine in PHEM buffer, and embedded gradually in gelatin (2, 5, and 12% in PHEM) before infiltration overnight in 2.3 M sucrose. Brain pieces were frozen in liquid nitrogen and sectioned at -120°C in a cryoultramicrotome (Leica EM UC6/FC6; Leica, Vienna, Austria). The sections were retrieved in Formvar-coated gold EM grids of 200 mesh using a mixture 1:1 of 2.3 M sucrose and 2% methyl cellulose. For immunogold labeling, the grids were sequentially incubated at 37ºC in 2% gelatin for 20 min, in 50 mM glycine in PHEM, in 5% bovine serum albumin (BSA) in PHEM, and finally in 2% BSA in PHEM. Incubation with the anti-CBF-A antibody SAK22 (1:7 vol/vol) and protein A gold conjugated (1:100 vol/vol) were also done in 2% BSA in PHEM for 1 h and 30 min, respectively. Washes were then done in PHEM. Grids were finally postfixed with 1% glutaraldehyde in PHEM, washed in distilled water, and stained with 2% methyl cellulose/ saturated uranyl acetate (9:1) for 10 min. The observations and images were made in a Tecnai Spirit 120 kv electron microscope (FEI, Eindhoven, The Netherlands).
Isolation of synaptosome-enriched fraction
Brain fractions were prepared as previously described (Huttner et al., 1983; Zhou et al., 2007) . Briefly, three adult mice were killed by cervical dislocation, and the forebrains were dissected out on ice. All of the following steps were performed at 4ºC. The tissues were quickly minced and homogenized in 10× volumes of 0.32 M sucrose buffer (0.32 M sucrose in 10 mM HEPES, pH.7.4) supplemented with protease inhibitors (Complete; Roche) with nine up-and-down strokes of a glass homogenizer. The homogenate was centrifuged at 1000 × g for 10 min, and supernatant (S1) was centrifuged again at 17,500 × g for 30 min. The pellet (P2) was dissolved into lysis buffer (0.4% NP-40, protease inhibitors in 1× PBS) and used for further experiments. For the characterization of each fraction, the same amount of proteins (20 μg/lane) was resolved by SDS-PAGE, detected by Coomassie staining, and analyzed on immunoblots with antibodies against CBF-A (ICCI), PSD-95, and H3.
Protein and RNA immunoprecipitation
Mouse brain P2 fractions were incubated overnight at 4ºC with anti-CBF-A antibody (ICCI), no antibody (mock), or nonspecific mouse IgGs (Dako). Where indicated, protein extracts were treated with the RNase inhibitor (100 μg/ml, RNaseout; Fermentas, Glen Burnie, MD) for 15 min before incubation with antibodies. In all cases the (Carpinteria, CA). For immunofluorescence experiments, the primary antibodies were revealed with species-specific fluorophoreconjugated (Cy3, Cy5 from Jackson ImmunoResearch, West Grove, PA; Alexa 488 from Molecular Probes, Eugene, OR) secondary antibodies.
Immunohistochemistry on mouse forebrain
Adult C57BL/6 mice (Charles River Laboratories, Wilmington, MA) were transcardially perfused with phosphate-buffered saline (PBS) followed by 4% formaldehyde in PBS, and brains were dissected and postfixed overnight at 4°C. Coronal sections were made at 35 μm using a vibratome (Leica, Wetzlar, Germany). Staining was performed on free-floating sections. Sections were incubated with blocking solution (10% donkey serum in PBS with 0.2% Triton X-100) for 1 h at room temperature and then incubated at 4°C for 14 h with primary antibody diluted in blocking solution. Primary antibodies against CBF-A (ICCI), Map2, NeuN, Synapsin I, and PSD95 were used on the sections. Primary antibodies were revealed with Cy3-, Cy5-, or Alexa 488-conjugated secondary antibodies. Control sections were stained with secondary antibodies alone.
